Target intelligence / Profile preview

RNA, U6 small nuclear 861, pseudogene (RNU6-861P)

Target: RNU6-861P
Molecular classification: Pseudogene, Non-coding RNA pseudogene, Small nuclear RNA pseudogene

Overview

RNU6-861P (RNA, U6 small nuclear 861, pseudogene) is a human pseudogene, meaning it is a non-functional genomic locus derived from the U6 small nuclear RNA (snRNA) gene family[3]. The functional U6 snRNA is an essential, highly conserved non-coding RNA involved in the spliceosome complex, enabling pre-mRNA splicing in the cell nucleus—an essential step of eukaryotic gene expression[1][3]. Pseudogenes such as RNU6-861P, in contrast, typically arise from gene duplication or retrotransposition events and lack the regulatory elements or structural integrity to be transcribed as functional genes[2][3]. While some pseudogenes have been shown in rare cases to regulate gene expression via RNA mechanisms, there is no evidence that RNU6-861P is functional in this way[2]. Pseudogenes are not considered direct drug targets or physiological receptors, enzymes, or transporters.

Other names: RNU6-861PRNA, U6 small nuclear 861, pseudogene

Mechanism of action

Not applicable

Biological functions

Other (no direct function; as a pseudogene, it is generally considered non-functional and does not produce an active RNA or protein product)Potential regulatory roles (very rare, and only in select pseudogenes, e.g., via RNA-mediated mechanisms as described for some pseudogenes)

Disease associations

Other (no direct link; some pseudogenes participate in gene regulation or have been weakly associated with disease mechanisms, but this is not established or described for RNU6-861P specifically)

Beyond the preview

Go deeper on RNA, U6 small nuclear 861, pseudogene (RNU6-861P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 861, pseudogene (RNU6-861P).

Explore the full profile